Hyponatremia – unfavourable prognostic factor in hepatic cirrhosis

1. EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis. J Hepatol. 2010; 53(3):397-417.10.1016/j.jhep.2010.05.004Search in Google Scholar

2. SCHRIER RW. Water and sodium retention in edematous disorders: Role of vasopressin and aldosterone. Am J Med. 2006; 119(7 Suppl 1):S47-53.10.1016/j.amjmed.2006.05.007Search in Google Scholar

3. ADROGUÉ HJ, MADIAS NE. Hyponatremia. N Engl J Med. 2000; 342(21):1581-9.10.1056/NEJM200005253422107Search in Google Scholar

4. BIGGINS SW, RODRIGUEZ HJ, BACCHETTI P, BASS NM, ROBERTS JP, TERRAULT NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005; 41(1):32-39.10.1002/hep.20517Search in Google Scholar

5. GINÈS P, CÁRDENAS A. The management of ascites and hyponatremia in cirrhosis. Semin Liver Dis. 2008; 28(1):43-58.10.1055/s-2008-1040320Search in Google Scholar

6. FOLLO A, LLOVET JM, NAVASA M, PLANAS R, FORNS X, FRANCITORRA A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994; 20(6): 1495-1501.10.1002/hep.1840200619Search in Google Scholar

7. ARROYO V, RODÉS J, GUTIÉRREZ-LIZÁRRAGA MA, REVERT L. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis. 1976; 21(3):249-56.10.1007/BF01095898Search in Google Scholar

8. LONDOÑO MC, GUEVARA M, RIMOLA A, NAVASA M, TAURÀ P, MAS A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006; 130(4):1135-43.10.1053/j.gastro.2006.02.017Search in Google Scholar

9. SOLÀ E, WATSON H, GRAUPERA I, TURÓN F, BARRETO R, RODRÍGUEZ E, et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol. 2012; 57(6):1199-206.10.1016/j.jhep.2012.07.020Search in Google Scholar

10. PEREIRA G, GUEVARA M, FAGUNDES C, SOLÁ E, RODRÍGUEZ E, FERNÁNDEZ J, et al. Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study. J Hepatol. 2012; 56(5):1040-46.10.1016/j.jhep.2011.11.023Search in Google Scholar

11. CÁRDENAS A, GINÈS P, MAROTTA P, CZERWIEC F, OYUANG J, GUEVARA M, et al. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol. 2012; 56(3):571-8.10.1016/j.jhep.2011.08.020Search in Google Scholar

12. BERL T, QUITTNAT-PELLETIER F, VERBALIS JG, SCHRIER RW, BICHET DG, OUYANG J, et al. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol. 2010; 21(4):705-12.10.1681/ASN.2009080857Search in Google Scholar